Memorial Sloan Kettering Cancer Center
Federica Valsecchi, PhD, currently serves as Project Management Lead for Immunotherapy at Memorial Sloan Kettering Cancer Center, where responsibilities include spearheading preclinical and clinical studies for cell therapy and facilitating collaboration between MSK investigators and pharmaceutical/biotech companies. Valsecchi co-founded the Italian Pancreatic Cancer Community in 2021 and has been the Founder and CEO of Fondazione Nadia Valsecchi since 2014, focusing on pancreatic cancer awareness, research, and patient care. Previous roles include Research Project Manager at The Lustgarten Foundation, overseeing significant research initiatives in pancreatic cancer, and a Fellow at Weill Cornell Medicine, contributing to medical innovations. Valsecchi is currently an MBA candidate at the Zicklin School of Business and holds a PhD from Radboud University, along with a Master of Science from Università di Pavia.
This person is not in any teams
This person is not in any offices
Memorial Sloan Kettering Cancer Center
9 followers
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.